– Focus on expanding U.S. market presence.
– Protein craze driving food industry investments.
– Local manufacturing established for U.S. distribution.
– Consumer trends favoring complete nutrition products.
▸ Full transcript
Into training not just our employees, not just people that are impacted, but the communities we serve as well, because that's the age we live in. That you're fixed income fix. Watch Bloomberg Real Yield every Thursday at 5 p.m. London time, right here on Bloomberg. Context changes everything. All right, let's check in on the state of the consumer, particularly with those U.S. retail sales out tomorrow. There's some data out there that says food makers are going all in on the protein craze. That's the brand behind Activa and Evian Water, acquiring the UK-based protein shake maker, Hewlett. The deal was for about $1.2 billion. And pleased to say the CEO of Hewlett joins us here in studio, James McMaster. Great to see you, man. Thank you. You know, I think about, I've been familiar with Hewlett for a while and I remember the only way you could get it was you had to go to the website, subscribe, and get a ship from the UK, I assume. I assume that's where it was coming from. But give me a sense as to what this provides in terms of reach being with the company the size of DeNone. Is this a play for the U.S. market? Is it just a play to be bigger in the UK and in Europe, what? Yes, we started out being about a brand that could be about complete nutrition. And actually, when we launched in the U.S. about eight years ago, we had local manufacturing, local warehouses. So we would have shipped from here. And then we've got to a place where we're a big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big, big.
Analysis
U.S. retail sales data is anticipated tomorrow, with food manufacturers heavily investing in the protein market, highlighted by DeNone's acquisition of UK-based protein shake maker Hewlett for approximately $1.2 billion. This move signals a strategic push into the U.S. market, aiming to capitalize on the growing consumer demand for protein-rich products.